Skip to main content
IFRS Academy

CERTYNEX IFRS ACADEMY

Search the Academy

Home
My learning path
Exercises & quizzes
Cases
Workpapers
Exams
My progress

Single choiceExpertPublished

Question · Uncertain tax treatments: measure and reassess

Arquevin's current tax liability for an uncertain treatment includes 120,000 for 20X1 and 90,000 for 20X2. In 20X5, the authority's right to re-examine 20X1 expires without an audit. Which treatment applies?

Your answer

← Back to the concept